Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LLEDO, G")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

V : Hémorragies : ulcères et angiomes = Hemorrhage : ulcer and angiomaLLEDO, G.Acta endoscopica. 1991, Vol 21, Num 1, pp 153-155, issn 0240-642X, SUPArticle

Programme personnalisé de soins: de la théorie à la pratique : Présentation d'un logiciel d'aide à la rédaction du programme personnalisé de soinsLLEDO, G; ARTRU, P.La Lettre du cancérologue (Boulogne). 2007, Num SEPT, pp 4-7, issn 1165-113X, 4 p., HSArticle

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 studyBIDARD, F.-C; TOURNIGAND, C; DE GRAMONT, A et al.Annals of oncology. 2009, Vol 20, Num 6, pp 1042-1047, issn 0923-7534, 6 p.Article

Novel (60%) and Recurrent (40%) Androgen Receptor Gene Mutations in a Series of 59 Patients with a 46,XY Disorder of Sex DevelopmentAUDI, L; FERNANDEZ-CANCIO, M; YESTE, D et al.The Journal of clinical endocrinology and metabolism. 2010, Vol 95, Num 4, pp 1876-1888, issn 0021-972X, 13 p.Article

Actualités sur l'oxaliplatine à l'ASCO 2003: Chicago, 31 mai - 3 juin 2003 = ASCO 2003 update on oxaliplatin : Chicago, 31 may - 3 june 2003ARTRU, P; LLEDO, G; LOUVET, C et al.La Lettre du cancérologue (Boulogne). 2003, Vol 12, Num 4, pp 4-9, issn 1165-113X, 6 p., SUP4Article

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: Final results of a GERCOR multicenter phase II studyLOUVET, C; ANDRE, T; LLEDO, G et al.Journal of clinical oncology. 2002, Vol 20, Num 6, pp 1512-1518, issn 0732-183XArticle

Cost-Minimisation Analysis in First-Line Treatment of Metastatic Colorectal Cancer in France: XELOX versus FOLFOX-6PERROCHEAU, G; BENNOUNA, J; DOUILLARD, J. Y et al.Oncology. 2010, Vol 79, Num 3-4, pp 174-180, issn 0030-2414, 7 p.Article

FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 studyCHIBAUDEL, B; TOURNIGAND, C; CAROLA, E et al.Annals of oncology. 2009, Vol 20, Num 8, pp 1383-1386, issn 0923-7534, 4 p.Article

Actualités sur l'oxaliplatine à L'ASCO 2004, La Nouvelle-Orléans, 5-8 juin 2004 [Comptes rendus]ARTRU, P; LLEDO, G; LOUVET, C et al.La Lettre du cancérologue (Boulogne). 2004, Vol 13, Num 5, issn 1165-113X, 15 p., SUP1Conference Proceedings

Oxaliplatine dans les cancers digestifs = Oxaliplatin in digestive cancerLa Lettre du cancérologue (Boulogne). 2004, Vol 13, Num 5, pp 4-13, issn 1165-113X, 10 p., SUP1Conference Paper

Modalités d'exercice de la cancérologie digestive par un hépato-gastro-entérologue (HGE) en secteur libéral = Practice mode of digestive oncology by a hepato-gastroenterologist in liberal settingLLEDO, G.Acta endoscopica. Supplément. 2003, Vol 33, Num 3, pp 462-463, issn 1242-1383, 2 p., SUPConference Paper

Radiothérapie à visée curative du carcinome du canal anal: impact défavorable d'une résection préalable. Étude rétrospective de 57 patients traités en intention curative = Definitive treatment of anal canal carcinoma with radiotherapy: Adverse impact of a pre-radiation resection. A retrospective study of 57 patients treated with curative intentCOQUARD, R; CENNI, J.-C; ARTRU, P et al.Cancer radiothérapie. 2009, Vol 13, Num 8, pp 715-720, issn 1278-3218, 6 p.Article

Actualités sur le cétuximab au 43rd ASCO 2007, Chicago, 1er-5 juin 2007ARTRU, P; FRANCOIS, E; LLEDO, G et al.La Lettre du cancérologue (Boulogne). 2007, Vol 16, Num 7, issn 1165-113X, 12 p., SUP4Serial Issue

Actualités sur l'oxaliplatine à l'ASCO 2005, Orlando, 13-17 mai 2005ARTRU, P; LLEDO, G; LOUVET, C et al.La Lettre du cancérologue (Boulogne). 2005, Vol 14, Num 4, issn 1165-113X, 15 p., SUP2Serial Issue

Lack of preferential transmission of diabetic HLA alleles by healthy parents to offspring in Spanish diabetic familiesMARTIN-VILLA, J. M; VICARIO, J. L; MARTINEZ-LASO, J et al.The Journal of clinical endocrinology and metabolism. 1990, Vol 70, Num 2, pp 346-348, issn 0021-972XArticle

Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerCONROY, T; HEBBAR, M; DOUILLARD, J. Y et al.British journal of cancer. 2010, Vol 102, Num 1, pp 59-67, issn 0007-0920, 9 p.Article

FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer : results of an Association des Gastro-Entérologues Oncologues (Gastroenterologist oncologist Association) multicenter phase II studyTAÏEB, J; LECOMTE, T; DESRAME, J et al.Annals of oncology. 2007, Vol 18, Num 3, pp 498-503, issn 0923-7534, 6 p.Article

Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteriaTRILLET-LENOIR, V; FREYER, G; MOINDROT, H et al.British journal of radiology. 2002, Vol 75, Num 899, pp 903-908, issn 0007-1285, 6 p.Article

Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish populationVICARIO, J. L; MARTINEZ-LASO, J; CORELL, A et al.Diabetologia (Berlin). 1992, Vol 35, Num 5, pp 475-481, issn 0012-186XArticle

Exclusive HLA-DQ factors do not explain susceptibility to insulin-dependent diabetesMARTINEZ-LASO, J; VICARIO, J. L; CORELL, A et al.Human immunology. 1991, Vol 31, Num 2, pp 134-138, issn 0198-8859, 5 p.Article

La cytologie de l'œsophage par brossage endoscopique. Intérêt dans le diagnostic du reflux gastro-œsophagien = Cytology on esophageal endoscopic brushing samples: value for the diagnosis of gastroesophageal refluxDIHL, F; MESGUICH, P; PAULIN, C et al.La Semaine des hôpitaux de Paris. 1989, Vol 65, Num 13, pp 801-807, issn 0037-1777Article

Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancerBOUCHAHDA, M; MACARULLA, T; LEVI, F et al.Critical reviews in oncology/hematology. 2008, Vol 67, Num 3, pp 255-262, issn 1040-8428, 8 p.Article

Observatoire du Cancer Colorectal : Résultats d'une enquête nationale de pratique en milieu libéral = Observatory of the Colorectal Cancer results of a national enquiry about private practicePIENKOWSKI, P; HOUCKE, Ph; LLEDO, G et al.Acta endoscopica. 2007, Vol 37, Num 2, pp 131-148, issn 0240-642X, 18 p.Conference Paper

A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patientsMABRO, M; ARTRU, P; ANDRE, T et al.British journal of cancer. 2006, Vol 94, Num 9, pp 1287-1292, issn 0007-0920, 6 p.Article

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer : Results of a GERCOR and GISCAD phase III trialLOUVET, C; LABIANCA, R; FAROUX, R et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3509-3516, issn 0732-183X, 8 p.Article

  • Page / 2